Jiyuan Wu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 28, 2025
Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial.
Journal: The British journal of dermatology
Published: August 25, 2025
Sensitivity and Specificity of Reflectance Confocal Microscopy and Dermoscopy in Assessing Vitiligo Staging.
Journal: Journal of cosmetic dermatology
Published: August 24, 2025
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial.
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial.
Journal: Journal of the American Academy of Dermatology
Published: April 28, 2025
Sensitivity and Specificity Analysis of Different Lesion Areas of Vitiligo by Reflectance Confocal Microscopy.
Journal: Journal of cosmetic dermatology
Published: June 27, 2024
In-depth study of Wood's lamp examination combined with reflective confocal laser scanning microscopy for the guidance of vitiligo staging and treatment.
Journal: Journal of cosmetic dermatology
Published: August 25, 2023
Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Journal: Cell death and differentiation
Published: April 30, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026